GILEAD SCIENCES, INC. Cost of Revenue 2007-2025 | GILD
Beta
What is cost of revenue?
Cost of revenue includes the direct costs attributable to producing goods or delivering services sold by the company.
What is GILEAD SCIENCES, INC.'s current cost of revenue?
GILEAD SCIENCES, INC. (GILD) annual cost of revenue for 2024 was $6.25B, a 3.80% decline from 2023. GILEAD SCIENCES, INC. cost of revenue for the quarter ending September 30, 2025 was $1.57B.
What was GILEAD SCIENCES, INC.'s cost of revenue in 2023?
GILEAD SCIENCES, INC. annual cost of revenue for 2023 was $6.50B, a 14.87% increase from 2022.
What was GILEAD SCIENCES, INC.'s cost of revenue in 2022?
GILEAD SCIENCES, INC. annual cost of revenue for 2022 was $5.66B, a 14.30% decline from 2021.
What is GILEAD SCIENCES, INC.'s 5-year cost of revenue CAGR?
GILEAD SCIENCES, INC. cost of revenue grew at a compound annual growth rate (CAGR) of 5.98% from FY2019 to FY2024, going from $4.67B to $6.25B over 5 years.
Cost of Revenue History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+6.0%
FY2019
$4.67B
→
FY2024
$6.25B
070809101112131415161718192021222324
5 years selected
Cost of Revenue History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2024 | $6.25B | -3.8% | 10-K |
| FY2023 | $6.50B | +14.9% | 10-K |
| FY2022 | $5.66B | -14.3% | 10-K |
| FY2021 | $6.60B | +44.4% | 10-K |
| FY2020 | $4.57B | -2.2% | 10-K |
| FY2019 | $4.67B | -3.7% | 10-K |
| FY2018 | $4.85B | +11.0% | 10-K |
| FY2017 | $4.37B | +2.6% | 10-K |
| FY2016 | $4.26B | +6.4% | 10-K |
| FY2015 | $4.01B | +5.8% | 10-K |
| FY2014 | $3.79B | +32.5% | 10-K |
| FY2013 | $2.86B | +15.7% | 10-K |
| FY2012 | $2.47B | +16.3% | 10-K |
| FY2011 | $2.12B | +13.6% | 10-K |
| FY2010 | $1.87B | +17.2% | 10-K |
| FY2009 | $1.60B | +41.5% | 10-K |
| FY2008 | $1.13B | +46.6% | 10-K |
| FY2007 | $768.8M | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →